The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
Catalent Pharma Solutions has appointed Marlene Leuenberger as General Manager of the company’s Drug Development Center of Excellence in Somerset, New Jersey.
Leuenberger has over 25 years’ management experience in engineering, quality operations,...
Almac Group, a Craigavon, UK-based contract development and manufacturing organization (CDMO) of active pharmaceutical ingredients (APIs) and drug products, plans to invest £375,000 ($496,000) in additional nuclear magnetic resonance (NMR)...
Catalent Pharma Solutions plans to adopt an optofluidic platform for cell-line development provided by Berkeley Lights (BLI), an Emeryville, California-headquartered company developing platforms for biopharmaceutical processes.
BLI’s Beacon...
Filament BioSolutions, a New York-headquartered development-stage therapeutics company, has formed a collaboration with Ajinomoto Co., a Tokyo, Japan-based manufacturer of amino acids, to develop Filament’s lead product, FB-2710, an oral...
Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has launched a stand-alone serialization service for meeting a compliance deadline of February 2019 for certain requirements of the European Union Falsified...
Amphastar Pharmaceuticals, a Rancho Cucamonga, California-based specialty pharmaceutical company, has announced plans to expand the scope of its subsidiary, Amphastar Nanjing Pharmaceuticals (ANP).
Amphastar is a specialty pharmaceutical...
Fermion Oy, a Espoo, Finland-based, a manufacture of small-molecule active pharmaceutical ingredients (APIs), has commissioned a new manufacturing facility in Hanko, Finland, to replace an older manufacturing unit.
Fermion Oy manufacturers APIs...
Evonik has announced plans to invest EUR 35 million ($41 million) to expand its contract development and manufacturing (CDMO) capabilities in North America for controlled-release injectable formulations. The expansion of Evonik’s US and Canadian...
WuXi Biologics, part of WuXi AppTec, a Shanghai, China-headquartered contract service provider, has formed a development and manufacturing pact with Immune Pharmaceuticals, a New York-headquartered clinical-stage biopharmaceutical company focused...
Abzena, a contract manufacturer of biologics and antibody drug conjugates, has signed manufacturing and bioconjugation agreements with Telix Pharmaceuticals, a Melbourne, Australia-based clinical-stage biopharmaceutical company. Telix specializes...
Bain Capital Private Equity, a private investment firm, has agreed to acquire DSM Sinochem Pharmaceuticals (DSP), a Singapore-headquartered producer of antibiotics, statins, and antifungals.
DSP is a 50/50 joint venture of Royal DSM, a life...
Bosch Packaging Technology has announced plans to sell its packaging machinery business.
“After intensively and thoroughly considering all its strategic options, the Bosch Group has decided to look for a buyer for its packaging machinery business...
Boehringer Ingelheim (BI) has completed a new filling line at its commercial manufacturing facility in Shanghai, China for its contract manufacturing business, BioXcellence. The new isolator-based fill/finish line is for GMP operations for aseptic...
Catalent has agreed to acquire Juniper Pharmaceuticals, a Boston, Massachusetts-headquartered specialty pharmaceutical company with contract development and manufacturing services, including its Nottingham, UK-based Juniper Pharma Services...
General Electric (GE) has announced plans to spin off GE Healthcare, its healthcare business, as a stand-alone company, following results from a strategic review. The plan is part of a larger reorganization and strategic alignment of the company....
